Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery

被引:42
作者
Lasbury, ME [1 ]
Durant, PJ [1 ]
Bartlett, MS [1 ]
Smith, JW [1 ]
Lee, CH [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
关键词
D O I
10.1128/CDLI.10.2.293-302.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Changes in the number of alveolar macrophages were correlated with organism burden during Pneumocystis carinii infection. The lungs of healthy, dexamethasone-treated and dexamethasone-treated and P. carinii-infected rats were lavaged with phosphate-buffered saline. Counting of alveolar macrophages in the lavage fluids revealed that P. carinii infection caused a 58% decrease in the number of alveolar macrophages and that higher P. carinii organism burdens caused a more rapid decrease in alveolar macrophage number. As a control, healthy rats were challenged with the same number of organisms as that normally used to generate P. carinii infections in dexamethasone-treated rats. Thirteen days after challenge, these rats had a profound (54%) increase in alveolar macrophage number in response to the challenge, while the number of alveolar macrophages in immunosuppressed and P. carinii-infected rats had decreased significantly by this time point. These experiments created the first animal model to mimic human pneumocystis pneumonia in alveolar macrophage number alterations. Reduction of P. carinii organism numbers by treatment of rats with trimethoprim and sulfamethoxazole brought a slow rebound in alveolar macrophage number, while recovery from P. carinii infection by cessation of immunosuppression brought a rapid rebound in alveolar macrophage number. These results suggest that both the immune state of the host and P. carinii burden affect alveolar macrophage number.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 44 条
[11]   DOWN-REGULATION OF THE ANTIGEN PRESENTING CELL FUNCTION(S) OF PULMONARY DENDRITIC CELLS INVIVO BY RESIDENT ALVEOLAR MACROPHAGES [J].
HOLT, PG ;
OLIVER, J ;
BILYK, N ;
MCMENAMIN, C ;
MCMENAMIN, PG ;
KRAAL, G ;
THEPEN, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :397-407
[12]   PROGNOSTIC RELEVANCE OF LYMPHOCYTE SUBPOPULATIONS AND MACROPHAGES IN THE PERIPHERAL-BLOOD AND THE BRONCHOALVEOLAR LAVAGE OF PATIENTS WITH AIDS AND SUSPECTED PNEUMOCYSTIS-CARINII INFECTION [J].
HUHN, C ;
NERL, C ;
SIEBERT, A ;
HOGL, L ;
DOERING, W ;
KABOTH, W ;
EICHENLAUB, D .
KLINISCHE WOCHENSCHRIFT, 1990, 68 (17) :853-856
[13]   ALVEOLAR MACROPHAGE RELEASE OF TUMOR-NECROSIS-FACTOR DURING MURINE PNEUMOCYSTIS-CARINII PNEUMONIA [J].
KOLLS, JK ;
BECK, JM ;
NELSON, S ;
SUMMER, WR ;
SHELLITO, J .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 8 (04) :370-376
[14]  
LANKEN PN, 1980, AM J PATHOL, V99, P561
[15]   PHAGOCYTOSIS AND STIMULATION OF THE RESPIRATORY BURST IN NEUTROPHILS BY PNEUMOCYSTIS-CARINII [J].
LAURSEN, AL ;
OBEL, N ;
RUNGBY, J ;
ANDERSEN, PL .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1466-1471
[16]   The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung [J].
Limper, AH ;
Hoyte, JS ;
Standing, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2110-2117
[17]   INTERACTION INVITRO OF PNEUMOCYSTIS-CARINII WITH MACROPHAGES AND L-CELLS [J].
MASUR, H ;
JONES, TC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (01) :157-170
[18]  
MCGAVRAN PD, 1990, J ENVIRON PATHOL TOX, V9, P377
[19]   PNEUMOCYSTIS-CARINII AS FOAMY EXUDATE IN BONE-MARROW [J].
MOMOSE, H ;
LEE, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (13) :1672-1672
[20]  
NEESE LW, 1994, J IMMUNOL, V152, P4549